What to confirm for a recurring hormone program
Ask your Olympia clinical liaison for written per-vial cost on each hormone formulation you prescribe — testosterone cypionate, estradiol, progesterone, Biest (50/50 and 80/20), anastrozole, and combination BHRT creams each carry different compounding costs. For a cadence program, confirm rate stability: is your quoted rate fixed, or does it renegotiate at intervals or volume tiers? A rate that drifts upward after you have set patient monthly program pricing erodes margin on a base of patients already on the program. Confirm vial size relative to dosing frequency so your per-dose cost reflects how often patients inject or apply, and confirm whether multi-month supply changes the economics.
Because hormone patients are long-horizon, also confirm what happens at contract renewal. If rates can change at renewal, model the downside so a future increase does not quietly turn a profitable hormone program unprofitable. The recurring nature of TRT and BHRT programs makes rate predictability a material concern — one that a verbal rate promise does not adequately address.